Rana Saifi: An Exciting Time for the Bleeding Disorders Community
Rana Saifi, Regional Manager of Middle East at World Federation of Hemophilia, shared World Federation of Hemophilia’s post on LinkedIn, adding:
“Exciting time for the bleeding disorders community with this high level advocacy led by WHO Member States and supported actively by the WFH.”
Quoting World Federation of Hemophilia’s post:
“Today, the World Federation of Hemophilia joins global health leaders at the World Health Organization 158th Executive Board meeting in Geneva EB158, where a landmark Member State-led resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders is on the agenda.
This resolution is led by Armenia with co-sponsorship by Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo.
The draft resolution text can be viewed on the WHO EB158 website.
Follow us on our social media channels today, as we will share WHO EB158 live streaming web-link, as the discussion on this resolution is planned to take place later today Treatment For All.”
More posts featuring Rana Saifi.
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis
-
Aug 15, 2026, 16:58Andrew Jackson: Oral Anticoagulants for the Prophylaxis of Catheter-Related Thrombosis
-
Aug 15, 2026, 16:52Understanding Blood Clots During Pregnancy and After Birth – Thrombosis UK
-
Aug 15, 2026, 16:39Liri Seraj: How Summer Dehydration Affects Blood and Thrombosis Risk
-
Aug 15, 2026, 16:29Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
-
Aug 15, 2026, 16:20Anoop Singh: When India Became the Key to a Faster Hemophilia A Trial